Research Phases

Axiom is the partner of choice for small to medium life sciences organizations. Our unified Fusion eClinical Suite has powered research from pre-clinical to post-marketing phases in more than 40 countries around the world.

We have dedicated 20 years accelerating studies for small-to-mid size life science companies across the globe, in over 30 specialized therapeutic areas, from pre-clinical to post-marketing phases.

Your study is unique. Find out how Axiom can help.

Connect with us about your unique study needs!


Research Phase Breakdown: Drug Studies

  • Phase I Studies – 27%
  • Phase II Studies – 23%
  • Phase III Studies – 18%
  • Phase IV / Registry – 24%
  • Post-Marketing Services – 8%

Research Phase Breakdown: Device Studies

  • Phase I Studies – 20%
  • Phase II Studies – 23%
  • Phase III Studies – 28%
  • Phase IV / Registry – 21%
  • Post-Marketing Services – 8%

Axiom works with Clients on Studies across the globe.

Countries where Axiom has supported studies in the past 6 months:

Your study is unique. Find out how Axiom can help!

Driving Collaboration via Real-Time Actionable Data: Axiom’s Fusion platform eliminates the labor-intensive manual tasks so often required by small-to-mid size companies in managing a clinical study or study platform.

Fill out our Demo form to help us understand your project needs!

Fill out our demo request form below, or visit our Contact page for more options to reach us!

Sign up for our monthly Fusion Newsletter today! Get updates on:

+ The latest Fusion features and upgrades
+ Upcoming industry events and company news
+ Early access to our latest white papers, case studies and webinars